Viking, on the BigBiz show, Les said we would handle GBM sales on our own, but would work with other companies on other indications depending on how much they were willing to pay. That's a paraphrase from memory. I respect your opinion that we won't be getting money from working with other BP on clinical tries, but I believe Les. So what did he mean? Will BPs who partner with us be putting up all the funds for the clinical trials? Will they be financing us on future research? Or will it be strictly Pay to Play, where the one willing to pay the most gets to trial with us? I strongly believe DCVax will be the hub of a giant wheel that any pharmaceutical company will be able to experiment with if they are willing to pay for the clinical trial.
Bullish
News 
Market Data 
Discover 
